Your account is not claimed yet. You can sign up with ORCID to claim your account.

Erin L Schenk (Erin Schenk)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ precision oncology

Journal of immunology (Baltimore, Md. : 1950)

Life science alliance

University of Colorado at Denver - Anschutz Medical Campus

Mayo Graduate School (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Colorado at Denver - Anschutz Medical Campus

United States

Assistant Professor :: Medical Oncology

Education History

Mayo Graduate School

United States

PHD :: Immunology

Publications

Katherine Priest, Anh Le, Amanuail Gebregzabheir, Hala Nijmeh, Gregory B Reis, Melanie Mandell, Kurtis D Davies, Carolyn Lawrence, Emily O'Donnell, Robert C Doebele, Liming Bao, Dara L Aisner, Erin L Schenk
Evolution of acquired resistance in a ROS1 + KRAS G12C + NSCLC through the MAPK pathway. NPJ precision oncology 7 (1) (2023)
Katherine Priest, Anh Le, Amanuail Gebregzabheir, Hala Nijmeh, Gregory B Reis, Melanie Mandell, Kurtis D Davies, Carolyn Lawrence, Emily O'Donnell, Robert C Doebele, Liming Bao, Dara L Aisner, Erin L Schenk
Evolution of acquired resistance in a ROS1 + KRAS G12C + NSCLC through the MAPK pathway. NPJ precision oncology 7 (1) (2023)
Emily K Kleczko, Trista K Hinz, Teresa T Nguyen, Natalia J Gurule, Andre Navarro, Anh T Le, Amber M Johnson, Jeff Kwak, Diana I Polhac, Eric T Clambey, Mary Weiser-Evans, Daniel T Merrick, Michael C Yang, Tejas Patil, Erin L Schenk, Lynn E Heasley, Raphael A Nemenoff
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. NPJ precision oncology 7 (1) (2023)
Katherine Priest, Anh Le, Amanuail Gebregzabheir, Hala Nijmeh, Gregory B Reis, Melanie Mandell, Kurtis D Davies, Carolyn Lawrence, Emily O'Donnell, Robert C Doebele, Liming Bao, Dara L Aisner, Erin L Schenk
Evolution of acquired resistance in a ROS1 + KRAS G12C + NSCLC through the MAPK pathway. NPJ precision oncology 7 (1) (2023)
Emily K Kleczko, Trista K Hinz, Teresa T Nguyen, Natalia J Gurule, Andre Navarro, Anh T Le, Amber M Johnson, Jeff Kwak, Diana I Polhac, Eric T Clambey, Mary Weiser-Evans, Daniel T Merrick, Michael C Yang, Tejas Patil, Erin L Schenk, Lynn E Heasley, Raphael A Nemenoff
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. NPJ precision oncology 7 (1) (2023)
Emily K Kleczko, Trista K Hinz, Teresa T Nguyen, Natalia J Gurule, Andre Navarro, Anh T Le, Amber M Johnson, Jeff Kwak, Diana I Polhac, Eric T Clambey, Mary Weiser-Evans, Daniel T Merrick, Michael C Yang, Tejas Patil, Erin L Schenk, Lynn E Heasley, Raphael A Nemenoff
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. NPJ precision oncology 7 (1) (2023)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B Leighl, Hirva Mamdani, Gregory A Masters, Pamela R Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J Riely, Andrew G Robinson, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, David R Spigel, Ishmael A Jaiyesimi
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Amber M Johnson, Bonnie L Bullock, Alexander J Neuwelt, Joanna M Poczobutt, Rachael E Kaspar, Howard Y Li, Jeff W Kwak, Katharina Hopp, Mary C M Weiser-Evans, Lynn E Heasley, Erin L Schenk, Eric T Clambey, Raphael A Nemenoff
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma. Journal of immunology (Baltimore, Md. : 1950) 204 (8) (2020)
Bonnie L Bullock, Abigail K Kimball, Joanna M Poczobutt, Alexander J Neuwelt, Howard Y Li, Amber M Johnson, Jeff W Kwak, Emily K Kleczko, Rachael E Kaspar, Emily K Wagner, Katharina Hopp, Erin L Schenk, Mary Cm Weiser-Evans, Eric T Clambey, Raphael A Nemenoff
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLC. Life science alliance 2 (3) (2019)

Erin L Schenk.css-eqlu8i{font-size:small;padding-left:4px;} (Erin Schenk)

Publication Activity (10 Years)

Top Topics

Top Venues

Erin L Schenk (Erin Schenk)